Vertigenius Raises $2.8M in Funding Round Led by Atlantic Bridge

Why It Matters

Remote monitoring transforms vestibular care, easing therapist backlogs and creating a multi‑billion‑dollar revenue stream in the world’s largest market for vertigo treatment.

Key Takeaways

• €2.55M (~$2.8M) round led by Atlantic Bridge.
• Wearable head sensor enables remote vertigo monitoring.
• 20 US clinics in 11 states treating 3,000 patients.
• US addressable market exceeds €3BN (~$3.3BN).
• Funding adds US sales directors, expands R&D in Ireland.

Pulse Analysis

Vertigo affects an estimated 390 million people worldwide, yet traditional care relies on in‑person vestibular therapy and home exercises with no objective way to track progress. Vertigenius’ wearable head sensor fills that gap by streaming real‑time balance data to clinicians, allowing treatment adjustments without additional visits. This capability not only improves patient outcomes but also addresses the chronic shortage of vestibular therapists, a bottleneck that has driven waiting lists in many health systems.

The recent €2.55 million (~$2.8 million) raise underscores investor confidence in remote‑patient‑monitoring solutions that can be reimbursed under U.S. insurance codes. With FDA registration secured, Vertigenius has already secured 20 clinics across 11 states, treating 3,000 patients and demonstrating early market traction. The infusion will fund two U.S. sales directors, expand the commercial footprint, and reinforce R&D, quality, and regulatory teams back in Ireland, positioning the company to capture a share of the €3 billion (~$3.3 billion) addressable market.

Beyond vertigo, Vertigenius exemplifies a broader shift in MedTech toward data‑driven, at‑home care models. As payers increasingly reward remote monitoring, devices that deliver clinically actionable insights become essential assets for providers. Vertigenius’ expansion plans into Europe and the Asia‑Pacific region signal a strategic push to standardize remote vestibular care globally, potentially prompting competitors to accelerate similar offerings. For investors, the company’s blend of novel technology, clear reimbursement pathways, and a sizable unmet need makes it a compelling play in the evolving digital health landscape.

Deal Summary

Irish MedTech startup Vertigenius announced the close of a €2.55M ($2.8M) funding round to fuel its US expansion. The round was led by Atlantic Bridge with participation from Enterprise Ireland, MedTech Syndicate, IRRUS Investments, Xcendra Ventures, Ascentifi and others. The capital will support hiring, R&D, and commercial growth in the US market.